BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2021
View Archived Issues
Phase I data presented for SHR-1701 in patients with NSCLC
Read More
Enrollment opens in phase IIa study of FM-101 for NAFLD and NASH
Read More
Preclinical data reported on MigVax-101 subunit oral vaccine for COVID-19
Read More
Spark Therapeutics patents compositions for secretable protein-induced immune tolerization
Read More
New EGFR inhibitors discovered at the Dana-Farber Cancer Institute
Read More
Yuhan Corp., Green Cross Corp. present new GLCT-1 inhibitors
Read More
Zhejiang Hisun Pharmaceutical divulges new RET and/or VEGFR-2 inhibitors
Read More
New HBV HBsAg secretion inhibitors synthesized at Arbutus Biopharma
Read More
Penpulimab is highly active in relapsed/refractory classical Hodgkin's lymphoma
Read More
Targovax presents 24-month data from phase I/II study of ONCOS-102 in mesothelioma
Read More
China's NMPA approves clinical trial application for sirolimus for injection (albumin-bound)
Read More
First patient dosed in phase I study of CID-103 in multiple myeloma
Read More
Sovateltide slows down the progression of Alzheimer's disease in phase II study
Read More
Berdazimer sodium shows promising efficacy in preclinical SARS-CoV-2 transmission model
Read More
Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts
Read More
Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy
Read More
Phase I data for seclidemstat in R/R Ewing sarcoma
Read More
Myelin renewal reverses AD cognitive dysfunction in mice
Read More
Circulating markers of collagen turnover tied to disease severity in ADPKD
Read More
Phase II proof-of-concept study of VX-864 in AATD meets primary endpoint
Read More
HiberCell begins phase Ia study of PERK inhibitor HC-5404-FU in metastatic solid tumors
Read More